<DOC>
	<DOCNO>NCT01637935</DOCNO>
	<brief_summary>To assess potential association pioglitazone bladder cancer compare non-pioglitazone user among patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Cohort Study Pioglitazone Bladder Cancer Patients With Type II Diabetes</brief_title>
	<detailed_description>Following guidance United States Food Drug Administration ( FDA ) European Medicines Agency , University Pennsylvania Kaiser Permanente Northern California ( KPNC ) design conduct study use KPNC database assess potential association pioglitazone bladder cancer among patient type 2 diabetes mellitus . The study conduct course 10 year , series interim analyse undertaken period provide sponsor ( Takeda ) appropriate regulatory agency . In 2011 , plan 5-year interim analysis study publish Diabetes Care . That report include data 1 January 1997 30 April 2008 . Following report data , request FDA additional fourth interim analysis 8 year include data 1 January 1997 31 December 2010 . In August 2011 FDA request inclusion sensitivity analysis ass change cohort entry criterion minimize leave censoring exposure . Included FDA request duration analysis antidiabetic medication . In August 2014 , final 10-year analysis complete submitted sponsor regulatory agency . Interim result previously post clinicaltrials.gov available public archive</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>The study cohort include patient establish diagnosis diabetes mellitus prior January 1 , 1997 newly diagnose prior December 31 , 2002 . Patients eligible study cohort meet follow criterion : 1 . As January 1 , 1997 diagnose diabetes mellitus , age 40 old member KPNC , 2 . They diagnose diabetes mellitus , reach age 40 January 1 , 1997 December 31 , 2002 KPNC member 40th birthday , 3 . Had diabetes mellitus age 40 older join KPNC January 1 , 1997 December 31 , 2002 . Diagnosis bladder cancer record KPNC cancer registry prior entry cohort within 6 month entry KPNC .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>